Nandini Venkateswaran, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cataract | 8 | 2022 | 828 | 2.650 |
Why?
|
Cataract Extraction | 5 | 2024 | 463 | 1.920 |
Why?
|
Lens, Crystalline | 3 | 2021 | 385 | 1.720 |
Why?
|
Lenses, Intraocular | 4 | 2024 | 139 | 1.610 |
Why?
|
Phacoemulsification | 4 | 2022 | 150 | 1.490 |
Why?
|
Conjunctival Neoplasms | 3 | 2021 | 77 | 1.460 |
Why?
|
Keratitis | 2 | 2022 | 240 | 1.240 |
Why?
|
Endothelium, Corneal | 3 | 2022 | 215 | 0.990 |
Why?
|
Lens Capsule, Crystalline | 2 | 2022 | 38 | 0.930 |
Why?
|
Lens Implantation, Intraocular | 3 | 2024 | 190 | 0.880 |
Why?
|
Conjunctiva | 4 | 2022 | 478 | 0.880 |
Why?
|
Descemet Stripping Endothelial Keratoplasty | 2 | 2022 | 112 | 0.870 |
Why?
|
Iris | 3 | 2022 | 231 | 0.760 |
Why?
|
Asclepias | 1 | 2020 | 1 | 0.730 |
Why?
|
Dendritic Cell Sarcoma, Follicular | 1 | 2020 | 30 | 0.710 |
Why?
|
Corneal Perforation | 1 | 2020 | 29 | 0.710 |
Why?
|
Eye Neoplasms | 2 | 2019 | 307 | 0.680 |
Why?
|
Corneal Edema | 1 | 2020 | 47 | 0.680 |
Why?
|
Corneal Diseases | 3 | 2021 | 539 | 0.660 |
Why?
|
Pemphigus | 1 | 2020 | 107 | 0.660 |
Why?
|
Ophthalmology | 2 | 2023 | 550 | 0.650 |
Why?
|
Paraneoplastic Syndromes | 1 | 2020 | 155 | 0.640 |
Why?
|
Eye Infections, Parasitic | 1 | 2018 | 26 | 0.620 |
Why?
|
Keratomileusis, Laser In Situ | 1 | 2019 | 84 | 0.620 |
Why?
|
Cysticercosis | 1 | 2018 | 34 | 0.620 |
Why?
|
Lightning Injuries | 1 | 2018 | 2 | 0.610 |
Why?
|
Endophthalmitis | 1 | 2021 | 260 | 0.590 |
Why?
|
Eye Diseases | 2 | 2013 | 653 | 0.580 |
Why?
|
Ectopia Lentis | 1 | 2016 | 20 | 0.550 |
Why?
|
Vitrectomy | 1 | 2018 | 391 | 0.490 |
Why?
|
Optic Disk | 1 | 2019 | 421 | 0.490 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2018 | 646 | 0.480 |
Why?
|
Eye Injuries | 1 | 2018 | 227 | 0.480 |
Why?
|
Marfan Syndrome | 1 | 2016 | 236 | 0.470 |
Why?
|
Surgery, Computer-Assisted | 2 | 2019 | 1003 | 0.450 |
Why?
|
Aniridia | 1 | 2013 | 36 | 0.440 |
Why?
|
Fluorouracil | 1 | 2018 | 1642 | 0.440 |
Why?
|
Keratoconjunctivitis | 1 | 2013 | 40 | 0.440 |
Why?
|
Anterior Chamber | 1 | 2013 | 194 | 0.420 |
Why?
|
Refractive Surgical Procedures | 1 | 2012 | 22 | 0.420 |
Why?
|
Gram-Positive Bacteria | 1 | 2013 | 176 | 0.410 |
Why?
|
Iris Diseases | 1 | 2012 | 36 | 0.410 |
Why?
|
Artificial Organs | 1 | 2013 | 149 | 0.400 |
Why?
|
Visual Acuity | 3 | 2024 | 2676 | 0.390 |
Why?
|
Glaucoma Drainage Implants | 1 | 2012 | 107 | 0.380 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 2013 | 342 | 0.360 |
Why?
|
Trabeculectomy | 1 | 2012 | 174 | 0.360 |
Why?
|
Eye Infections, Bacterial | 1 | 2013 | 241 | 0.360 |
Why?
|
Ophthalmic Solutions | 3 | 2021 | 311 | 0.320 |
Why?
|
Vision Disorders | 2 | 2013 | 1089 | 0.310 |
Why?
|
Cornea | 3 | 2021 | 1327 | 0.310 |
Why?
|
Microscopy, Acoustic | 2 | 2021 | 47 | 0.300 |
Why?
|
Retina | 1 | 2018 | 2656 | 0.290 |
Why?
|
Diagnostic Imaging | 1 | 2021 | 3534 | 0.280 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2019 | 4021 | 0.270 |
Why?
|
Tomography, Optical Coherence | 4 | 2021 | 2923 | 0.270 |
Why?
|
Funnel Chest | 1 | 2023 | 74 | 0.210 |
Why?
|
Internship and Residency | 1 | 2023 | 5885 | 0.200 |
Why?
|
Amphotericin B | 1 | 2022 | 141 | 0.200 |
Why?
|
Descemet Membrane | 1 | 2022 | 71 | 0.200 |
Why?
|
Keratoconus | 1 | 2023 | 113 | 0.190 |
Why?
|
Carnobacteriaceae | 1 | 2021 | 10 | 0.190 |
Why?
|
Trigeminal Nerve Diseases | 1 | 2021 | 48 | 0.190 |
Why?
|
Pupil Disorders | 1 | 2021 | 33 | 0.180 |
Why?
|
Polyesters | 1 | 2022 | 371 | 0.180 |
Why?
|
Sclera | 1 | 2022 | 189 | 0.180 |
Why?
|
Meibomian Glands | 1 | 2020 | 73 | 0.180 |
Why?
|
Complex Regional Pain Syndromes | 1 | 2021 | 121 | 0.170 |
Why?
|
Keratoplasty, Penetrating | 1 | 2021 | 143 | 0.170 |
Why?
|
Humans | 34 | 2024 | 761222 | 0.170 |
Why?
|
Corneal Topography | 1 | 2019 | 68 | 0.170 |
Why?
|
Platelet-Rich Plasma | 1 | 2022 | 178 | 0.160 |
Why?
|
Keratoacanthoma | 1 | 2019 | 33 | 0.160 |
Why?
|
Anterior Eye Segment | 1 | 2020 | 143 | 0.160 |
Why?
|
Microscopy, Confocal | 2 | 2021 | 1967 | 0.150 |
Why?
|
Corneal Transplantation | 1 | 2022 | 322 | 0.150 |
Why?
|
Ophthalmoscopy | 1 | 2018 | 171 | 0.150 |
Why?
|
Conjunctivitis, Allergic | 1 | 2018 | 125 | 0.150 |
Why?
|
Vancomycin | 1 | 2021 | 503 | 0.140 |
Why?
|
Alkylating Agents | 1 | 2017 | 133 | 0.140 |
Why?
|
Postoperative Complications | 3 | 2021 | 15637 | 0.140 |
Why?
|
Fundus Oculi | 1 | 2018 | 557 | 0.140 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2021 | 12159 | 0.140 |
Why?
|
Mitomycin | 1 | 2017 | 263 | 0.140 |
Why?
|
Conjunctival Diseases | 1 | 2017 | 109 | 0.130 |
Why?
|
Uveitis | 1 | 2020 | 396 | 0.130 |
Why?
|
Ophthalmologic Surgical Procedures | 1 | 2019 | 353 | 0.130 |
Why?
|
Viscosity | 1 | 2016 | 335 | 0.130 |
Why?
|
Antineoplastic Agents | 1 | 2018 | 13632 | 0.130 |
Why?
|
Intraocular Pressure | 3 | 2021 | 1294 | 0.130 |
Why?
|
Tissue Scaffolds | 1 | 2022 | 932 | 0.130 |
Why?
|
Comprehension | 1 | 2021 | 619 | 0.120 |
Why?
|
Cyclophosphamide | 1 | 2020 | 2219 | 0.120 |
Why?
|
Perception | 1 | 2021 | 1198 | 0.120 |
Why?
|
Fluorescein Angiography | 1 | 2018 | 1062 | 0.100 |
Why?
|
Aged | 9 | 2024 | 169292 | 0.100 |
Why?
|
Gonioscopy | 1 | 2012 | 155 | 0.100 |
Why?
|
Female | 12 | 2024 | 392552 | 0.090 |
Why?
|
Glaucoma | 1 | 2020 | 1186 | 0.090 |
Why?
|
Referral and Consultation | 2 | 2020 | 3608 | 0.090 |
Why?
|
Heart-Assist Devices | 1 | 2020 | 1288 | 0.080 |
Why?
|
Curriculum | 1 | 2023 | 3741 | 0.080 |
Why?
|
DNA, Bacterial | 1 | 2013 | 1470 | 0.080 |
Why?
|
Male | 10 | 2023 | 360703 | 0.070 |
Why?
|
Middle Aged | 6 | 2021 | 220858 | 0.070 |
Why?
|
Glaucoma, Open-Angle | 1 | 2012 | 739 | 0.060 |
Why?
|
Retrospective Studies | 5 | 2021 | 80675 | 0.060 |
Why?
|
Aged, 80 and over | 3 | 2019 | 58952 | 0.050 |
Why?
|
Adolescent | 4 | 2021 | 88300 | 0.050 |
Why?
|
Biological Dressings | 1 | 2021 | 30 | 0.050 |
Why?
|
Iran | 1 | 2023 | 736 | 0.040 |
Why?
|
Muscle Weakness | 1 | 2023 | 412 | 0.040 |
Why?
|
Nerve Growth Factor | 1 | 2021 | 157 | 0.040 |
Why?
|
Follow-Up Studies | 2 | 2019 | 39127 | 0.040 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2018 | 9278 | 0.040 |
Why?
|
Tissue Adhesions | 1 | 2021 | 218 | 0.040 |
Why?
|
Remission, Spontaneous | 1 | 2019 | 384 | 0.040 |
Why?
|
Tears | 1 | 2020 | 251 | 0.040 |
Why?
|
Cryotherapy | 1 | 2019 | 160 | 0.040 |
Why?
|
Diagnosis, Differential | 1 | 2013 | 12976 | 0.040 |
Why?
|
Anesthesia, Local | 1 | 2020 | 277 | 0.040 |
Why?
|
Young Adult | 2 | 2021 | 59222 | 0.040 |
Why?
|
Reading | 1 | 2021 | 531 | 0.040 |
Why?
|
Atrophy | 1 | 2021 | 1633 | 0.030 |
Why?
|
Dry Eye Syndromes | 1 | 2020 | 387 | 0.030 |
Why?
|
Child, Preschool | 2 | 2020 | 42225 | 0.030 |
Why?
|
Cosmetic Techniques | 1 | 2017 | 147 | 0.030 |
Why?
|
United States | 1 | 2023 | 72341 | 0.030 |
Why?
|
Benchmarking | 1 | 2021 | 1045 | 0.030 |
Why?
|
Motivation | 1 | 2024 | 2002 | 0.030 |
Why?
|
Regeneration | 1 | 2022 | 1505 | 0.030 |
Why?
|
Recombinant Proteins | 1 | 2021 | 6504 | 0.020 |
Why?
|
Adult | 2 | 2023 | 221120 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2022 | 3552 | 0.020 |
Why?
|
Pilot Projects | 1 | 2019 | 8642 | 0.020 |
Why?
|
Imaging, Three-Dimensional | 1 | 2019 | 4052 | 0.020 |
Why?
|
Prospective Studies | 2 | 2020 | 54437 | 0.020 |
Why?
|
Body Mass Index | 1 | 2020 | 12952 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2019 | 64681 | 0.010 |
Why?
|
Pandemics | 1 | 2021 | 8663 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2021 | 26072 | 0.010 |
Why?
|
Mutation | 1 | 2023 | 30004 | 0.010 |
Why?
|
Child | 1 | 2020 | 80154 | 0.010 |
Why?
|